PRA Health Sciences (PRAH) Tops Q1 EPS by 10c

PRA Health Sciences (NASDAQ: PRAH) reported Q1 EPS of $0.41, $0.10 better than the analyst estimate of $0.31. Revenue for the quarter came in at $332 million versus the consensus estimate of $329.8 million.

PRA Health Sciences sees FY2015 EPS of $1.62-$1.72, versus the consensus of $1.41.

For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low